| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |